• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对四种尼古丁替代产品的偏好和反应的个体差异。

Individual differences in preferences for and responses to four nicotine replacement products.

作者信息

West R, Hajek P, Nilsson F, Foulds J, May S, Meadows A

机构信息

St George's Hospital Medical School, Cranmer Terrace, London, UK.

出版信息

Psychopharmacology (Berl). 2001 Jan 1;153(2):225-30. doi: 10.1007/s002130000577.

DOI:10.1007/s002130000577
PMID:11205423
Abstract

RATIONALE

With several different forms of nicotine replacement therapy available for smokers, it is useful to know about factors that may influence choice of form.

OBJECTIVE

To examine factors associated with preference for different nicotine replacement products and effectiveness of these products. The simple comparison of success rates between the products has been reported previously.

METHODS

Five hundred and four smokers were invited to rank order four products (gum, patch, nasal spray and inhaler) in terms of preference and were then randomly allocated to receive one of the products for a smoking cessation attempt. They were followed up 1 week, 4 weeks, 12 weeks and 15 weeks later. Ratings of the products were repeated 1 week after the quit date. Mood and physical symptoms were assessed at baseline and at each follow-up visit. Urges to smoke were assessed at all post-quit date sessions. Abstinence was assessed by self-report with expired air carbon monoxide verification.

RESULTS

The patch was the most popular product initially, followed by the spray and inhaler and then the gum. The difference was greater for women than men. However, all smokers quickly came to like whichever product they had been allocated. Smokers who initially preferred the spray or inhaler were heavier smokers than those who preferred the gum or patch. Prior experience of the gum was associated with lower initial preference for it, but did not affect outcome. Prior experience with the patch had no effect on preference or outcome. Being allocated to the preferred product did not increase success at stopping smoking. Women were more successful at stopping smoking on the inhaler than the gum. Among highly dependent smokers, those on the inhaler had a lower relapse rate than those on the other products.

CONCLUSIONS

Regardless of initial preferences, whether patients obtain their preferred form of NRT or one selected for them did not seem to affect outcome. This may be because smokers came to like particular products as they got used to them. Other things being equal, women may be better advised to use inhaler rather than gum and men vice versa.

摘要

原理

由于有几种不同形式的尼古丁替代疗法可供吸烟者使用,了解可能影响剂型选择的因素很有用。

目的

研究与不同尼古丁替代产品偏好相关的因素以及这些产品的有效性。此前已报道过产品之间成功率的简单比较。

方法

邀请504名吸烟者按照偏好对四种产品(口香糖、贴片、鼻喷雾剂和吸入器)进行排序,然后随机分配接受其中一种产品以尝试戒烟。在1周、4周、12周和15周后对他们进行随访。在戒烟日期后1周重复对产品的评级。在基线和每次随访时评估情绪和身体症状。在所有戒烟日期后的时段评估吸烟冲动。通过自我报告并经呼出气体一氧化碳验证来评估戒烟情况。

结果

贴片最初是最受欢迎的产品,其次是喷雾剂和吸入器,然后是口香糖。女性与男性之间的差异更大。然而,所有吸烟者很快就开始喜欢他们所分配到的任何产品。最初喜欢喷雾剂或吸入器的吸烟者比喜欢口香糖或贴片的吸烟者烟瘾更大。以前使用过口香糖与对其较低的初始偏好相关,但不影响结果。以前使用过贴片对偏好或结果没有影响。被分配到首选产品并不会提高戒烟成功率。女性使用吸入器戒烟比使用口香糖更成功。在高度依赖的吸烟者中,使用吸入器的人复发率低于使用其他产品的人。

结论

无论最初的偏好如何,患者获得他们首选的尼古丁替代疗法剂型还是为他们选择的剂型似乎都不会影响结果。这可能是因为吸烟者随着对特定产品的习惯而开始喜欢它们。在其他条件相同的情况下,女性可能最好使用吸入器而不是口香糖,男性则相反。

相似文献

1
Individual differences in preferences for and responses to four nicotine replacement products.对四种尼古丁替代产品的偏好和反应的个体差异。
Psychopharmacology (Berl). 2001 Jan 1;153(2):225-30. doi: 10.1007/s002130000577.
2
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4.
3
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD000146. doi: 10.1002/14651858.CD000146.pub3.
4
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2004(3):CD000146. doi: 10.1002/14651858.CD000146.pub2.
5
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2002(4):CD000146. doi: 10.1002/14651858.CD000146.
6
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2001(3):CD000146. doi: 10.1002/14651858.CD000146.
7
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2000(3):CD000146. doi: 10.1002/14651858.CD000146.
8
Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler.尼古丁聚半乳糖醛酸酯、透皮贴剂、鼻喷雾剂和吸入器的随机对照试验。
Arch Intern Med. 1999 Sep 27;159(17):2033-8. doi: 10.1001/archinte.159.17.2033.
9
Nicotine replacement therapy for smoking cessation.用于戒烟的尼古丁替代疗法。
Cochrane Database Syst Rev. 2000(2):CD000146. doi: 10.1002/14651858.CD000146.
10
A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy.
Respiration. 2007;74(2):196-201. doi: 10.1159/000097136. Epub 2006 Nov 14.

引用本文的文献

1
Testing the feasibility of the QuitAid smoking cessation intervention in a randomized factorial design in an independent, rural community pharmacy.在一个独立的农村社区药房,采用随机析因设计测试戒烟辅助戒烟干预措施的可行性。
Pilot Feasibility Stud. 2024 Feb 26;10(1):41. doi: 10.1186/s40814-024-01465-9.
2
Vaping for weight control: A cross-sectional population study in England.电子烟控制体重:英格兰的一项横断面人群研究。
Addict Behav. 2019 Aug;95:211-219. doi: 10.1016/j.addbeh.2019.04.007. Epub 2019 Apr 6.
3
The Association Between Epoxide Hydrolase Genetic Variant and Effectiveness of Nicotine Replacement Therapy in a Han Chinese Population.
汉族人群中环氧水解酶基因变异与尼古丁替代疗法疗效的关联
Neurosci Bull. 2016 Dec;32(6):545-546. doi: 10.1007/s12264-016-0074-1. Epub 2016 Oct 25.
4
Gender and stimulus control of smoking behavior.吸烟行为的性别差异与刺激控制
Nicotine Tob Res. 2015 Apr;17(4):431-7. doi: 10.1093/ntr/ntu195.
5
Relationships of PROP Taste Phenotype, Taste Receptor Genotype, and Oral Nicotine Replacement Use.PROP味觉表型、味觉受体基因型与口腔尼古丁替代疗法使用之间的关系。
Nicotine Tob Res. 2015 Sep;17(9):1149-55. doi: 10.1093/ntr/ntu281. Epub 2014 Dec 26.
6
Client preferences affect treatment satisfaction, completion, and clinical outcome: a meta-analysis.患者偏好影响治疗满意度、治疗完成情况及临床结局:一项荟萃分析。
Clin Psychol Rev. 2014 Aug;34(6):506-17. doi: 10.1016/j.cpr.2014.06.002. Epub 2014 Jun 16.
7
Sex differences in response to reduced nicotine content cigarettes.对尼古丁含量降低的香烟的反应中的性别差异。
Addict Behav. 2014 Jul;39(7):1197-204. doi: 10.1016/j.addbeh.2014.03.021. Epub 2014 Mar 30.
8
High dose transdermal nicotine for fast metabolizers of nicotine: a proof of concept placebo-controlled trial.高剂量透皮尼古丁治疗尼古丁快速代谢者:一项概念验证安慰剂对照试验。
Nicotine Tob Res. 2013 Feb;15(2):348-54. doi: 10.1093/ntr/nts129. Epub 2012 May 15.
9
Harm reduction therapy: a practice-friendly review of research.减少伤害疗法:一项便于实践的研究综述。
J Clin Psychol. 2010 Feb;66(2):201-14. doi: 10.1002/jclp.20669.
10
Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.尼古丁贴片与尼古丁锭在戒烟方面的效果比较:由社区肿瘤临床方案协调进行的一项有效性试验。
Drug Alcohol Depend. 2010 Mar 1;107(2-3):237-43. doi: 10.1016/j.drugalcdep.2009.11.001. Epub 2009 Dec 9.